| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |